- Home
- CANF vs BWBBP Comparison
CANF vs BWBBP Comparison
Compare CANF & BWBBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CANF | BWBBP |
|---|---|---|
| Founded | 1994 | N/A |
| Country | Israel | United States |
| Employees | N/A | 322 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7M | N/A |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | CANF | BWBBP |
|---|---|---|
| Price | $3.26 | $20.35 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9,750.00 | N/A |
| AVG Volume (30 Days) | ★ 613.1K | 2.1K |
| Earning Date | 03-26-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $461.72 | N/A |
| Revenue Next Year | $290,391.28 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.17 | $18.10 |
| 52 Week High | $10.40 | $22.48 |
Technical Indicators
Market Signals| Indicator | CANF | BWBBP |
|---|---|---|
| Relative Strength Index (RSI) | 38.61 | 51.67 |
| Support Level | $0.59 | $19.09 |
| Resistance Level | $4.74 | $20.83 |
| Average True Range (ATR) | 0.20 | 0.21 |
| MACD | -0.08 | -0.05 |
| Stochastic Oscillator | 11.29 | 30.65 |
Price Performance
Historical ComparisonAbout CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.
About BWBBP Bridgewater Bancshares Inc.
Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.